Subscribe
gil-c-shutterstock-com-johnson-johnson-
Gil C / Shutterstock.com
4 January 2017Americas

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board (PTAB) decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Johnson & Johnson unit settles patent dispute over hypertension drug
28 January 2021   In a win for Johnson & Johnson, its Actelion unit has settled an infringement lawsuit after generic drug maker Laurus conceded that a patent for a pulmonary hypertension drug was valid.
Americas
J&J reaches $6m settlement over counterfeit surgical tools
9 February 2021   Johnson & Johnson has settled its case against Advanced Inventory Management, trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Johnson & Johnson unit settles patent dispute over hypertension drug
28 January 2021   In a win for Johnson & Johnson, its Actelion unit has settled an infringement lawsuit after generic drug maker Laurus conceded that a patent for a pulmonary hypertension drug was valid.
Americas
J&J reaches $6m settlement over counterfeit surgical tools
9 February 2021   Johnson & Johnson has settled its case against Advanced Inventory Management, trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.

More on this story

Americas
Johnson & Johnson unit settles patent dispute over hypertension drug
28 January 2021   In a win for Johnson & Johnson, its Actelion unit has settled an infringement lawsuit after generic drug maker Laurus conceded that a patent for a pulmonary hypertension drug was valid.
Americas
J&J reaches $6m settlement over counterfeit surgical tools
9 February 2021   Johnson & Johnson has settled its case against Advanced Inventory Management, trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.

More features

GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Herbert Smith Freehills and Kramer Levin in $2bn merger talks
Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman
President Trump 2.0: Five major areas to watch